Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel (Q24632899)

2

0 references

Joel Baranski

3

0 references

James E Bourdeau

4

0 references

Anatole Besarab

5

0 references

Alice S Appel

6

0 references

Jai Radhakrishnan

7

0 references

Gerald B Appel

Drug Design, Development and Therapy

8

0 references

language of work or name

English

0 references

publication date

2011

0 references

published in

0 references

volume

5

0 references

page(s)

147-53

0 references

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

start time

1 March 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3063118

Interventions for minimal change disease in adults with nephrotic syndrome

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3063118

Melanocortin 1 receptor agonists reduce proteinuria

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3063118

Successful treatment of membranous glomerulonephritis with rituximab in calcineurin inhibitor-dependent patients

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3063118

Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3063118

Adult minimal-change disease: clinical characteristics, treatment, and outcomes.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3063118

Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3063118

Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3063118

A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3063118

Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3063118

Case series of idiopathic membranous nephropathy with long-term beneficial effects of ACTH peptide 1-24.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3063118

A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3063118

ACTH-induced improvement in the nephrotic syndrome in patients with a variety of diagnoses.

28 November 2018

1 reference